Health
Penn Study Finds Solid-Tumor Cancer Patients Ineligible for Clinical Trials Receive Immunotherapy at Greater Rates Despite Lack of Benefits – Newswise
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients…
Newswise — PHILADELPHIA — Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the…
Continue Reading
-
General24 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
General24 hours agoTariff letters to 12 countries going out Monday: Trump
-
General23 hours agoNRL live updates: Canberra Raiders vs St George Illawarra Dragons, North Queensland Cowboys vs Melbourne Storm
-
General23 hours agoWA road toll hits decade high as five people killed in 24 hours